Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Ju Fu Tang Biotech Holdings Co Quick Ratio Related Terms
Ju Fu Tang Biotech Holdings Co Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08217 vs PWR, FIX, EME: Quick Ratio Comparison
For the Engineering & Construction subindustry, Ju Fu Tang Biotech Holdings Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ju Fu Tang Biotech Holdings Co Quick Ratio vs Construction Industry
For the Construction industry and Industrials sector, Ju Fu Tang Biotech Holdings Co's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Ju Fu Tang Biotech Holdings Co's Quick Ratio falls into.
Ju Fu Tang Biotech Holdings Co Quick Ratio Calculation
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a Quick Ratio of 2.20 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. This is 38% above median its historical median of 1.60. Over the past decade, Ju Fu Tang Biotech Holdings Co's Quick Ratio has ranged from 1.06 to 2.20. According to the industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #353 out of 1789 companies in the Construction industry, placing it in the top 19.7%.
Is Ju Fu Tang Biotech Holdings Co's Quick Ratio too high?
Ju Fu Tang Biotech Holdings Co's current Quick Ratio of 2.20 is 38% above median its 10-year median of 1.60. Over the past 10 years, this metric has ranged from a low of 1.06 to a high of 2.20. The Construction industry median Quick Ratio is 1.29. Ju Fu Tang Biotech Holdings Co's value of 2.20 is 70.5% above this industry median. Based on the distribution chart, Ju Fu Tang Biotech Holdings Co ranks #353 out of 1789 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's Quick Ratio compare to PWR and FIX?
According to the Construction industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #353 out of 1789 companies for Quick Ratio. This places Ju Fu Tang Biotech Holdings Co in the top 20% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.29. Ju Fu Tang Biotech Holdings Co's value of 2.20 is 70.5% above this benchmark. Historically, Ju Fu Tang Biotech Holdings Co's own Quick Ratio has ranged from 1.06 to 2.20 over the past decade. While the company's 10-year median is 1.60 vs. the industry median of 1.29, Ju Fu Tang Biotech Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Construction company?
The median Quick Ratio among Construction companies is 1.29, based on 1,789 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ju Fu Tang Biotech Holdings Co's current Quick Ratio of 2.20 is 70.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. For the Construction industry, the median Quick Ratio is 1.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current Quick Ratio is 2.20, which is 38% above median its own 10-year median of 1.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 26% below its estimated fair value. The current Quick Ratio is 2.20, which is 38% above median its 10-year median of 1.60 and 70.5% above the Construction industry median of 1.29. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current Quick Ratio is 2.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued.
The current stock price of HK$0.11 is trading 26% below its estimated GF Value™ of HK$0.15.
GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.
Key valuation signals for HKSE:08217:
Quick Ratio: 2.20 (38% above median its 10-year median of 1.60)
GF Value™: HK$0.15 vs. price of HK$0.11 (26% below fair value)
Industry Position: 70.5% above the Construction median (#353 of 1789)
No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score
Get the complete analysis for HKSE:08217
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08217 has been successfully added to your 
